NFKB1 and acute lymphoblastic leukemia: Congruent with this, inhibition of either ATM using KU-60019 or the NF-kB pathway using pyrrolidinedithiocarbamate ammonium (PDTC) enhanced chemo sensitivity in an ALL xenograft model (28).